health news today obesity drugs glp-1 Retatrutide for weight loss: Study shows 30% body weight loss GLP-1 medicines entered clinical use
Description
How Ozempic Works: GLP-1 Agonist Despite the hype surrounding Ozempic, its mechanism of action is not novel
24 March 2023
In this narrative literature review, we explore the pharmacological properties of tirzepatide and critically summarize and comment on the results of the clinical studies conducted thus far, as well as discuss the potential implications for the treatment of obesity, T2DM, and associated cardiometabolic complications
These three receptor pathways form the foundation of next-generation multi-agonist therapies that deliver deeper, more sustained weight-loss and metabolic improvements than single-target drugs
Clinical trials have shown their efficacy and safety over several years, yet the possibility of long-term adverse effects remains a research focus
However, this was just the beginning
